|
Dechra Pharmaceuticals PLC - veterinary products firm - Signs private placement of €50 million seven year and €100 million ten year senior unsecured notes. Weighted average coupon of the fixed rate notes will equate to 3.8%. Says issue has similar covenants to existing facilities. ‘The private placement is being undertaken now to achieve the group's aim of ensuring diversified sources of funding and to extend the group's debt maturity profile. All proceeds from the placement will be used to repay existing debt on the group's revolving credit facility.’ Dechra says.
Current stock price: 3,548.00 pence, up 0.3% in London on Thursday
12-month change: down 24%
Copyright 2022 Alliance News Limited. All Rights Reserved.
|
